---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-224656"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2022-08-19T23:59:59+00:00"
generated_at: "2026-06-23T22:36:00.844164+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Kymera raises $150M PIPE with 2.77M shares at $26 and 3M pre-funded warrants

## Summary
- Private placement of 2,769,228 common shares at $26.00 and 3,000,000 pre-funded warrants at $25.9999.
- Gross proceeds of ~$150M expected; closing on August 22, 2022 subject to customary conditions.
- Proceeds to fund working capital, R&D, and general corporate purposes.
- Post-closing cash, equivalents, and investments expected to exceed $600M as of August 31, 2022.
- Offering led by a US healthcare fund and BVF; includes Avoro, EcoR1, Redmile, Rock Springs, T. Rowe Price.

## SEC filing metadata
- accession: 0001193125-22-224656
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2022-08-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/0001193125-22-224656-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/d247240d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-224656
- JSON: https://secwatch.observer/filing/0001193125-22-224656.json
- Plain text: https://secwatch.observer/filing/0001193125-22-224656.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.